Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To raise awareness and enhance the diagnosis of patients with chronic low back pain(CLBP) with a neuropathic pain component who are refractory to standard analgesic therapy and/or one treatment for neuropathic pain in a primary care setting and assess the effectiveness and tolerability of pregabalin in this group of patients. To assess patient satisfaction with treatment with pregabalin in patients with CLBP with a neuropathic pain component who are refractory to standard analgesic therapy and/or one treatment for neuropathic pain in a primary care setting.
Inclusion criteria
- Pregabalin (Lyrica ®) is approved in the European Union for the treatment of peripheral and central neuropathic pain in adults. The medical condition being investigated in this study is chronic neuropathic low back pain